The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 3-(2-hydroxyethyl)-5-methyl-2,4-dioxo-1-(2-phenylethyl)thieno[2,3-d]pyrimidine-6-carboxylate ID: ALA4476176
PubChem CID: 8072533
Max Phase: Preclinical
Molecular Formula: C20H22N2O5S
Molecular Weight: 402.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1sc2c(c1C)c(=O)n(CCO)c(=O)n2CCc1ccccc1
Standard InChI: InChI=1S/C20H22N2O5S/c1-3-27-19(25)16-13(2)15-17(24)21(11-12-23)20(26)22(18(15)28-16)10-9-14-7-5-4-6-8-14/h4-8,23H,3,9-12H2,1-2H3
Standard InChI Key: QYWCWTDAWUBHFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
27.4709 -14.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1787 -13.9770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8905 -14.3845 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.8905 -15.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1787 -15.6152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4709 -15.2036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6926 -15.4578 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
26.2114 -14.7960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6927 -14.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4808 -13.3432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3927 -14.7960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9853 -15.5034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.9853 -14.0886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.1666 -14.0886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7593 -13.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1787 -16.4340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8902 -16.8413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8902 -17.6600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5976 -18.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5965 -18.8828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8887 -19.2944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1811 -18.8878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1784 -18.0698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5980 -15.6150 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5980 -13.9772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3054 -14.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0128 -13.9772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1787 -13.1583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 1 0
6 5 1 0
1 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
1 9 1 0
9 10 1 0
8 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
5 16 1 0
16 17 1 0
17 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
4 24 2 0
3 25 1 0
25 26 1 0
26 27 1 0
2 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 402.47Molecular Weight (Monoisotopic): 402.1249AlogP: 1.94#Rotatable Bonds: 7Polar Surface Area: 90.53Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.11CX LogD: 3.11Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -1.41
References 1. Romero FA, Jones CT, Xu Y, Fenaux M, Halcomb RL.. (2020) The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease., 63 (10): [PMID:31930920 ] [10.1021/acs.jmedchem.9b01701 ]